Literature DB >> 16211465

Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis.

Edwin Roger Parra1, Yonara Rivelle David, Lígia Rodrigues Silvério da Costa, Alexandre Ab'Saber, Rogerio Sousa, Ronaldo Adib Kairalla, Carlos Roberto Ribeiro de Carvalho, Mario Terra Filho, Vera Luiza Capelozzi.   

Abstract

Recently, several reports suggest differences in the vascularization of the various histopathologic patterns of parenchymal remodeling seen in usual interstitial pneumonia (UIP). In this study, we sought to validate the importance of vascular remodeling in patients with idiopathic pulmonary fibrosis (IPF) and to examine the relationship between vascular remodeling and parenchymal remodeling or pulmonary function. Open lung biopsies were performed in 57 patients with IPF, and vascular changes in alternating areas of parenchymal remodeling (UIP histologic patterns) were studied. Quantitative analysis of the internal area, internal perimeter, wall thickness, and surrounding cellularity of medium or large pulmonary arteries, as well as their distribution according to air/parenchymal ratios, was performed. Semiquantitative analysis also was used to determine the grade of vascular occlusion. An inverse association was found between vascularization and UIP parenchymal remodeling (p < 0.05); that is, the decreased internal luminal area and perimeter as well as the increased wall thickness run in parallel with progression from alveolar collapse toward severe mural-organizing fibrosis with honeycombing. Vascular regression (diminished internal area and perimeter of vessels) was also associated with higher FEV(1), FVC, and RV values (r = 0.48, p< 0.05), reflecting a tight relationship between vascular remodeling and pulmonary function. A progressive regression of vascularization, reflected by different degrees of luminal occlusion after vascular remodeling, coincided with parenchymal remodeling (alveolar collapse, mural-organizing fibrosis, and honeycombing). This vascular regression may be responsible for the impaired wound healing and progressive fibroproliferation found in patients with IPF. Further studies are needed to determine whether this relationship is causal or consequential.

Entities:  

Mesh:

Year:  2005        PMID: 16211465     DOI: 10.1007/s00408-004-2542-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  17 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  PRECAPILLARY SYSTEMIC-PULMONARY ANASTOMOSES.

Authors:  M TURNER-WARWICK
Journal:  Thorax       Date:  1963-09       Impact factor: 9.139

Review 3.  Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance.

Authors:  M Cutaia; S Rounds
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study.

Authors:  A L Katzenstein
Journal:  Hum Pathol       Date:  1985-10       Impact factor: 3.466

6.  Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin.

Authors:  M N Peão; A P Aguas; C M de Sá; N R Grande
Journal:  Anat Rec       Date:  1994-01

7.  The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage.

Authors:  Y Fukuda; M Ishizaki; Y Masuda; G Kimura; O Kawanami; Y Masugi
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

8.  Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study.

Authors:  A L Katzenstein; J L Myers; M T Mazur
Journal:  Am J Surg Pathol       Date:  1986-04       Impact factor: 6.394

9.  Intraluminal fibrosis in interstitial lung disorders.

Authors:  F Basset; V J Ferrans; P Soler; T Takemura; Y Fukuda; R G Crystal
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

10.  Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis.

Authors:  Y Fukuda; V J Ferrans; C I Schoenberger; S I Rennard; R G Crystal
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

View more
  11 in total

1.  Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias.

Authors:  Edwin Roger Parra; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro de Carvalho; Vera Luiza Capelozzi
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

2.  Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia.

Authors:  Edwin Roger Parra; Walcy R Teodoro; Ana Paula Pereira Velosa; Cristiane Carla de Oliveira; Natalino Hajime Yoshinari; Vera Luiza Capelozzi
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

3.  Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.

Authors:  Ahmed Fahim; Michael G Crooks; Alyn H Morice; Simon P Hart
Journal:  Lung       Date:  2014-01-07       Impact factor: 2.584

Review 4.  3D culture models for studying branching morphogenesis in the mammary gland and mammalian lung.

Authors:  Bryan A Nerger; Celeste M Nelson
Journal:  Biomaterials       Date:  2018-08-23       Impact factor: 12.479

5.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Authors:  Laszlo Farkas; Daniela Farkas; Kjetil Ask; Antje Möller; Jack Gauldie; Peter Margetts; Mark Inman; Martin Kolb
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

6.  Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1.

Authors:  Robert Eferl; Peter Hasselblatt; Martina Rath; Helmut Popper; Rainer Zenz; Vukoslav Komnenovic; Maria-Helena Idarraga; Lukas Kenner; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205

7.  Lymphatic fluctuation in the parenchymal remodeling stage of acute interstitial pneumonia, organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis.

Authors:  E R Parra; C A L Araujo; J G Lombardi; A M Ab'Saber; C R R Carvalho; R A Kairalla; V L Capelozzi
Journal:  Braz J Med Biol Res       Date:  2012-04-12       Impact factor: 2.590

8.  Vascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance.

Authors:  E R Parra; R Falzoni; V L Capelozzi
Journal:  Braz J Med Biol Res       Date:  2012-04-26       Impact factor: 2.590

9.  Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis.

Authors:  Gregoire Ruffenach; Soban Umar; Mylene Vaillancourt; Jason Hong; Nancy Cao; Shervin Sarji; Shayan Moazeni; Christine M Cunningham; Abbas Ardehali; Srinivasa T Reddy; Rajan Saggar; Gregory Fishbein; Mansoureh Eghbali
Journal:  EMBO Mol Med       Date:  2019-08-29       Impact factor: 12.137

Review 10.  Lymphatic Vessel Regression and Its Therapeutic Applications: Learning From Principles of Blood Vessel Regression.

Authors:  Faisal Masood; Rohan Bhattaram; Mark I Rosenblatt; Andrius Kazlauskas; Jin-Hong Chang; Dimitri T Azar
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.